As of 2025-09-18, the EV/EBITDA ratio of Revolution Medicines Inc (RVMD) is -12.17. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RVMD's latest enterprise value is 7,786.97 mil USD. RVMD's TTM EBITDA according to its financial statements is -639.94 mil USD. Dividing these 2 quantities gives us the above RVMD EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-09-11 | -12.88 |
| 2025-09-10 | -11.19 |
| 2025-09-09 | -11.33 |
| 2025-09-08 | -11.36 |
| 2025-09-05 | -11.20 |
| 2025-09-04 | -10.75 |
| 2025-09-03 | -10.99 |
| 2025-09-02 | -10.92 |
| 2025-08-29 | -10.46 |
| 2025-08-28 | -10.57 |
| 2025-08-27 | -10.48 |
| 2025-08-26 | -10.26 |
| 2025-08-25 | -9.79 |
| 2025-08-22 | -10.18 |
| 2025-08-21 | -10.03 |
| 2025-08-20 | -9.93 |
| 2025-08-19 | -10.04 |
| 2025-08-18 | -10.02 |
| 2025-08-15 | -9.98 |
| 2025-08-14 | -9.89 |
| 2025-08-13 | -9.91 |
| 2025-08-12 | -9.67 |
| 2025-08-11 | -9.51 |
| 2025-08-08 | -9.59 |
| 2025-08-07 | -9.58 |
| 2025-08-06 | -10.08 |
| 2025-08-05 | -10.58 |
| 2025-08-04 | -10.23 |
| 2025-08-01 | -10.07 |
| 2025-07-31 | -10.26 |
| 2025-07-30 | -10.18 |
| 2025-07-29 | -10.18 |
| 2025-07-28 | -10.25 |
| 2025-07-25 | -10.44 |
| 2025-07-24 | -10.24 |
| 2025-07-23 | -10.33 |
| 2025-07-22 | -10.55 |
| 2025-07-21 | -10.59 |
| 2025-07-18 | -10.56 |
| 2025-07-17 | -10.78 |
| 2025-07-16 | -10.59 |
| 2025-07-15 | -10.42 |
| 2025-07-14 | -10.58 |
| 2025-07-11 | -10.48 |
| 2025-07-10 | -10.62 |
| 2025-07-09 | -10.62 |
| 2025-07-08 | -10.02 |
| 2025-07-07 | -10.08 |
| 2025-07-03 | -10.43 |
| 2025-07-02 | -10.23 |